Severity
Critical
FDA Drug recall · Reported February 22, 2017
Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine.
Jersey Shore Supplements, LLC recalled SLIMFIT X capsules, packaged in a 60-cont bottle - a critical-severity action.
SLIMFIT X capsules, packaged in a 60-cont bottle was recalled by Jersey Shore Supplements, LLC in February 22, 2017. Reason: Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine.. Check the official notice for the remedy. Verify recall #D-0473-2017 with the FDA Drug before acting.
The recall
Jersey Shore Supplements, LLC issued this critical-severity FDA Drug recall-Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine..
Sourced from official FDA Drug enforcement records. Verify recall #D-0473-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-0473-2017) was formally reported on February 22, 2017, with the manufacturer initiating the action on December 9, 2016. It is classified under Critical severity (Class I), with a current status of Terminated. Jersey Shore Supplements, LLC is listed as the recalling firm, operating out of Bradley Beach, NJ. Federal records list the affected scope as 150 bottles.
The documented reason for this recall is: Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine. Distribution data in the federal record shows the product reached: New Jersey and Maryland.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 3,731 children & baby products recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
150 bottles
Related Recalls
6
0 from same agency
SLIMFIT X capsules, packaged in a 60-cont bottle
Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and desmethylsibutramine.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-0473-2017 |
| Date reported | February 22, 2017 |
| Date initiated | December 9, 2016 |
| Recalling firm | Jersey Shore Supplements, LLC |
| Firm location | Bradley Beach, NJ |
| Affected scope | 150 bottles |
| Distribution | New Jersey and Maryland. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Xishentang Dongguan Trading Co, Ltd., dba Pretty-Life, of China · 2026-07-02
Diamond Wipes International, Inc. of Chino, California · 2026-07-02
· 2026-07-02
· 2026-07-02
Sanven Technology Ltd., dba Vevor, of Rancho Cucamonga, California · 2026-07-02
Compare this recall with AMASKY Nursing Pillows Recalled Due to Risk of Serious Inju… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 22, 2017. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.